Outcome of a Triple Inner Branched Aortic Arch Stentgraft. A Prospective, Multicenter Registry.
Recruiting
- Conditions
- Triple BranchAortic Arch AneurysmDissection of Aortic ArchAortic Arch
- Registration Number
- NCT05530304
- Lead Sponsor
- University Hospital Muenster
- Brief Summary
Outcome of a triple inner branched aortic arch stentgraft. A prospective, mulitcenter registry.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- 18 years or older
- Presence of Aortic arch pathology
- Treatment planned with triple inner branch from Terumo Aortic
- Availability of the patients during the follow up period
- Informing patients about the study and providing written informed consent
Exclusion Criteria
- Women of childbearing age
- Patients under 18 years
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method feasibility in terms of cannulation and stentgrafting of the three branches During intervention Stroke 30 days after intervention Mortality 30 days after intervention
- Secondary Outcome Measures
Name Time Method Patency rate of branches during the follow up period of 3 year primary and secondary
Stroke during the follow up period of 3 year Morbidity during the follow up period of 3 year Access issue, paraplegia, kidney failure
Endoleaks Type I and III during intervention and the follow up period of 3 year Longterm mortality during the follow up period of 3 year
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does the triple inner branched stentgraft design compare to standard aortic arch repair techniques in terms of aneurysm exclusion rates?
What biomarkers predict long-term patency of inner branched stentgrafts in aortic arch dissection patients?
What are the primary adverse events reported in triple inner branched stentgraft trials for thoracic aortic pathologies?
How does the triple inner branched stentgraft address challenges in treating complex aortic arch aneurysms compared to fenestrated devices?
What molecular mechanisms underlie aortic wall remodeling after triple inner branched stentgraft deployment in NCT05530304?
Trial Locations
- Locations (1)
Muenster University Hospital
🇩🇪Münster, Germany
Muenster University Hospital🇩🇪Münster, GermanyAlexander Oberhuber, MD PhdPrincipal Investigator